GAITHERSBURG, MD--(Marketwire - Mar 12, 2013) - Cytomedix, Inc. ( OTCQX : CMXI ) (the "Company"), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announced today that the Company will release financial results for the three- and twelve-months ended December 31, 2012, after the close of the market on Monday, March 18, 2013.
Martin Rosendale, Chief Executive Officer, and Andrew Maslan, Chief Financial Officer, will host a conference call beginning at 8:30am Eastern time on Tuesday, March 19, 2012 to discuss the fourth quarter and fiscal year 2012 results and to answer questions. James Hinson, MD, Chief Medical Officer, will join the call to discuss progress made on rolling out Coverage with Evidence Development for AutoloGel.
Conference Call & Webcast
Tuesday, March 19, 2013 @ 8:30am Eastern/5:30am Pacific